Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "risk"

1498 News Found

KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures
Healthcare | May 05, 2026

KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures

Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness


Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital
interviews | May 04, 2026

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows


ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines
News | May 04, 2026

ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines

Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners


Moderna posts Q1 2026 loss despite revenue surge
News | May 04, 2026

Moderna posts Q1 2026 loss despite revenue surge

Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets


Health ministry releases new healthcare safety guidelines
Policy | May 04, 2026

Health ministry releases new healthcare safety guidelines

Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities


FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote
News | May 04, 2026

FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote

The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer


Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive
News | May 04, 2026

Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive

The initiative pairs consumer engagement with a public health message about prevention and early detection


FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer
News | May 04, 2026

FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor


Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors
People | May 03, 2026

Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors

Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure


Bayer pushes stroke prevention drug forward in China as regulators accept key filing
News | May 02, 2026

Bayer pushes stroke prevention drug forward in China as regulators accept key filing

Stroke is the second-leading cause of death and the third-leading cause of disability worldwide